ReviewArchivos peruanos de cardiologia y cirugia cardiovascular
Recommendations for the management of ST-elevation myocardial infarction after reperfusion.
Review in Archivos peruanos de cardiologia y cirugia cardiovascular. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Betabloqueadores en pacientes posinfarto de miocardio.Archivos peruanos de cardiologia y cirugia cardiovascularArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The management of ST-segment elevation myocardial infarction (STEMI) after reperfusion requires critical decision-making in patients with multivessel disease (MVD), acute heart failure, and left ventricular (LV) thrombus. Complete revascularisation of non-culprit lesions ≥70% is recommended either during the index procedure or within the first 19 days, particularly in haemodynamically stable patients. Coronary artery bypass grafting is indicated for high-risk anatomy or complex lesions following successful percutaneous coronary intervention, where a hybrid approach may combine percutaneous intervention with surgery, and timing should be adjusted according to whether a stent was implanted. Post-infarction heart failure, which occurs in 28-31% of cases, requires urgent management; continuous monitoring and timely intervention can reduce complications. In patients with cardiogenic shock or mechanical complications, intra-aortic balloon pump support and inotropes may be necessary. Right ventricular infarction is managed with volume resuscitation, urgent revascularisation, and, when required, pharmacological support or pacing. LV thrombus, more frequent after anterior infarction with LVEF <50%, mandates early detection by echocardiography and/or tomography, and prompt anticoagulation, preferably with warfarin, with triple therapy considered in patients at high thrombotic risk. This manuscript outlines recommendations to optimise prognosis through early, evidence-based, and individualised interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.